Clinician-to-Clinician Update Clinician-to-Clinician Update

Pediatric Specialty Updates

November 2014

We are pleased to announce the new name of our children's hospital: University of Minnesota Masonic Children's Hospital.

UMMCH Hospital-Shot-443x304
— University of Minnesota Health has named the hospital in recognition of the Minnesota Masonic Charities' legacy of support to the University of Minnesota, particularly focused on supporting health care and research.

Two new award-winning physicians join the pediatric hematology/oncology team

We welcome two new physicians to our team: Peter Gordon, MD, PhD, and Lucie Turcotte, MD, MPH.

— Peter Gordon, MD, PhD

Dr. Gordon completed his fellowship in pediatric hematology, oncology and bone marrow transplantation in 2010 at Boston Children’s Hospital/Dana Farber Cancer Institute. After completing his fellowship, Dr. Gordon served as an Instructor in pediatric hematology/oncology until 2014, during which time he also completed post-doctoral research fellowships in the laboratories of Dr. David Fisher (Massachusetts General Hospital) and Dr. David Williams (Children’s Hospital Boston) where his work focused on the role of the proto-oncogene c-KIT in cancer development. Dr. Gordon recently won the Leukemia and Lymphoma Society New Idea Award to support his investigations into the use of gold nanoparticles for the treatment of hematological malignancies.

— Lucie Turcotte, MD

Dr. Turcotte completed her fellowship in pediatric hematology, oncology and bone marrow transplant in 2013 at University of Minnesota Masonic Children’s Hospital. During her fellowship, she also completed coursework for a Master of Science in Clinical Research. Dr. Turcotte’s research has focused on second malignancies and short- and long-term outcomes in pediatric cancer survivors. She has specific clinical interest in childhood leukemias and lymphomas, as well as in histiocytic disorders. For her outstanding research, she was awarded the 2014 Hyundai Hope On Wheels Young Investigator Clinical Research Award to study risk factors for the development of the metabolic syndrome in cancer survivors.

Related Articles

November 2014

Patient with Unique Biologic Subtype of Acute T-Lymphoblastic Leukemia Benefits from Multidisciplinary Care

A 7-year-old girl presented at her local clinic with fever, cough and bilateral leg pain that was focused in the knees and lower legs. She was diagnosed with double pneumonia and a newly described type of ALL, called early T-lymphocyte precursor AAL (EPT-ALL).

Continue reading

November 2014

Forging New Paths in Pediatric Leukemia and Lymphoma Care

Our specialists are determined and passionate about curing cancer and disease in children. Through research and clinical trials, treatment outcomes for pediatric leukemia and lymphoma have improved significantly.

Continue reading